Key facts
- Luminate Medical’s last known valuation is $74.5M (Jan 2026).
- It has raised $34.6M across 2 recorded rounds; the latest was Later Stage VC (Series A) ($21.0M) in Jan 2026.
- Notable investors include Y Combinator, Enterprise Ireland, European Innovation Council, Metaplanet Holdings, 8VC — 23 tracked in total.
- Luminate Medical has filed 3 Form Ds with the SEC since 2024, most recently Nov 2025 ($17.0M sold to 18 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Luminate Medical
Funding rounds
2 roundsAbout Luminate Medical
Developer of novel devices designed to make cancer care better for patients. The company provides a portable and wearable system that maintains confidence and dignity during treatment, enabling patients to avoid and control the side effects of cancer treatment.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2019
- Employees
- 60
- Website
- luminatemed.com/
- Ownership
- Privately Held (backing)
Luminate Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Luminate Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Luminate Medical in its N-PORT filings yet. We sweep new filings monthly.